ABSTRACT
INTRODUCTION
Tobacco and alcohol use by American high school students has been declining since the mid-1990s. Marijuana use followed a similar trend until the mid-2000s, when, according to data from Monitoring the Future, there was an increase in the percentage of high school students who reported having smoked marijuana in the past 30 days accompanied by a sharp decrease in the percentage of 10 th and 12 th graders who view regular marijuana use as risky (Johnston et al. 2011 ). Federal officials, including the Director of the Office of National Drug Control Policy (also known as the "Drug Czar"), have attributed these developments to the legalization of medical marijuana, noting that the medical marijuana industry has grown dramatically since the mid-2000s.
In an effort to combat youth marijuana use, John Walsh, the U.S. Attorney for Colorado, recently sent letters to medical marijuana dispensaries located within 1,000 feet of schools asking them to relocate or close. Walsh cited figures from the Colorado Department of Education showing that drug-related school suspensions, expulsions and law enforcement referrals increased dramatically from 2008 through 2011 (Ingold 2012) , and he was quoted as saying that many school districts in Colorado "have seen a dramatic increase in student abuse of marijuana, with resulting student suspensions and discipline" (McCrimmon and Jones 2012) . Melinda
Haag, the U.S. Attorney for the Northern California district, has targeted dispensaries located within 1,000 feet of schools, parks and playgrounds, arguing that marijuana serves as a gateway 2 drug and that, because "brains are not fully developed until your mid 20s", youth are particularly susceptible to its effects (Brooks 2012) . Local law enforcement authorities have also argued that there is a connection between the legalization of medical marijuana and the use of marijuana by teenagers. For instance, Tim O'Connell, the Deputy Police Chief in Billings, Montana, was quoted by Uken (2012) as saying, "We are definitely seeing an increase in the schools, and it's definitely related to bad legislation…We can thank the passage of legalizing marijuana."
There is, in fact, evidence that adolescents and young adults who use marijuana are more likely to use other substances such as alcohol and cocaine (Saffer and Chaloupka 1999; DeSimone and Farrelly 2003; Williams et al. 2004; Yörük and Yörük 2011) , as well as evidence that they are more likely to suffer from mental health problems (Fergusson et al. 2003; Van Ours and Williams 2011) , partake in risky sexual behaviors (Rashad and Kaestner 2004) , and do poorly in school (Yamada et al. 1996; Roebuck et al. 2003; Van Ours and Williams 2009 ).
However, only two previous studies have examined the relationship between medical marijuana laws (hereafter MMLs) and marijuana use among minors. 1 Drawing on data from the National Survey on Drug Use and Health (NSDUH) for the years 2002 through 2007, Wall et al. (2011) found that rates of marijuana use among 12-through 17-year-olds were higher in states that had legalized medical marijuana than in states that had not, but noted that "in the years prior to MML passage, there was already a higher prevalence of use and lower perceptions of risk" in states that had legalized medical marijuana (p. 714). Drawing on NSDUH data for the years 2002 through 1 Several studies have examined the relationship between MMLs and marijuana consumption without focusing on minors. Khatapoush and Hallfors (2004) used data on 16-though 25-year-olds living in California and 10 other states. They found no evidence that marijuana consumption went up after California legalized medical marijuana in 1996. Using data for the period 1995-2002 from Denver, Los Angeles, Portland, San Diego and San Jose, Gorman and Huber Jr. (2007) found little evidence that marijuana consumption increased among adult arrestees as a result of the legalization of medical marijuana. Cerdá et al. (2012) examined the cross-sectional relationship between MMLs and marijuana use among adults 18 years of age and above.
3 2009, Harper et al. (2012) found that legalization was associated with a small reduction in the rate of marijuana use among 12-through 17-year-olds.
The current study examines the relationship between MMLs and marijuana consumption among high school students using data from the national and state Youth Risky Behavior Surveys (YRBS) for the years 1993 through 2011. These data cover a period when 16 states, including Alaska, California, Maine, Oregon and Washington, legalized medical marijuana.
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The NSDUH did not provide information on substance use at the state level prior to 1999. As a consequence, neither Wall et al. (2011 ) nor Harper et al. (2012 had information on substance use among 12-through 17-year-olds in these states before legalization occurred.
Another advantage to using the YRBS data is that they contain information on the behavior and characteristics of individuals, allowing us to examine the relationship between MMLs and marijuana use by age and gender. With two exceptions (Khatapoush and Hallfors 2004; Cerdá et al. 2012) , previous studies in this area have relied on aggregate data, despite the fact that the choice to smoke marijuana is made at the individual level. Finally, the YRBS data contain information on marijuana use and drug availability at school, and the use of other substances such as alcohol and cocaine. These outcomes are of special interest given the current efforts in California and Colorado to close dispensaries operating near schools and because Melinda Haag, the U.S. Attorney for the Northern California district, has explicitly argued that marijuana is a gateway drug. Our results suggest that the legalization of medical marijuana was not accompanied by increases in the use of marijuana or other substances such as alcohol and In addition to analyzing data from the YRBS, we conduct two complementary analyses.
The first uses data from the National Longitudinal Survey of Youth 1997 (NLSY97). The behavior of NLSY97 respondents can be observed over time, allowing for the estimation of models that control for unobserved heterogeneity at the individual level. The second uses data from the Treatment Episode Data Set (TEDS), which contains information from drug treatment providers on patients who reported using marijuana before being admitted. These analyses provide further evidence that youth marijuana consumption did not increase with the legalization of medical marijuana.
BACKGROUND
In 1996, California became the first state to legalize medical marijuana. Since then, 16 additional states and the District of Columbia have legalized medical marijuana, and more than a dozen state legislatures are currently considering medical marijuana bills (Klofas and Letteney 2012) . In addition to removing criminal penalties for using, possessing and cultivating medical marijuana, medical marijuana laws provide immunity from prosecution to physicians who recommend medical marijuana to their patients.
While the therapeutic properties of marijuana are the subject of debate (Gilman 2005; Cohen 2009 ), the client base of doctors who recommend medical marijuana has expanded to include adolescents with conditions such as autism, insomnia, obsessive compulsive disorder, and attention deficit hyperactivity disorder (Browstein 2009; Ellison 2009; Joseph et al. 2010 ).
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Advocates of recommending medical marijuana for these conditions maintain that it is safer than alternative medicines such as methylphenidate (also known as "Ritalin"), the stimulant most often prescribed to treat attention deficit hyperactivity disorder (Lucido 2004; Ellison 2009) , and zolpidem tartrate (also known as "Ambien"), a medication prescribed to treat insomnia (Chaboya-Hembree 2012).
Patients under the age of 18 must have the permission of a parent or legal caregiver in order to use medical marijuana, and must be accompanied by a parent or legal caregiver when visiting a dispensary (Ellison 2009 (Pacula et al. 2010 ). Not surprisingly, past research has shown that attitudes and perceptions with regard to the harmfulness of marijuana are strongly correlated with use (Bachman et al. 1998; Pacula et al. 2001 ).
Our empirical analysis is reduced-form, based on the approach taken by previous researchers interested in the determinants of marijuana use. For instance, Farrelly et al. (1999) examined the reduced-form relationship between more stringent anti-marijuana policies and marijuana use, while Thies and Register (1993) , Saffer and Chaloupka (1999) and Williams These studies provide some evidence that marijuana use is sensitive to changes in policy.
For example, Farrelly et al. (1999) found that stricter enforcement of marijuana laws by police and higher fines for marijuana possession decreased use among adults. However, Farrelly et al. (1999) found that these policies had little impact on marijuana use among those under the age of 21. Using data from the United States, Thies and Register (1993) found that decriminalization did not lead to increased use of marijuana, while Saffer and Chaloupka (1999) found that decriminalization increased the probability of having smoked marijuana in the past 30 days.
Using Australian data, Williams (2004) found that decriminalization increased marijuana use among males over the age of 25, but had no effect on marijuana use by females or by younger males. Finally, Farrelly et al. (2001) found that cigarette taxes were negatively related to 7 marijuana use, while Williams et al. (2004) found that cigarette prices were essentially unrelated to marijuana use.
THE DATA
The primary data for this study come from the national and state YRBS. They are at the individual (micro) level and cover the period 1993 through 2011. 6 The national YRBS is conducted biennially by the Centers for Disease Control and Prevention (CDC) and is a nationally representative sample of U.S. high school students. Federal agencies rely upon the national YRBS to track trends in adolescent behavior including eating and exercise habits, violence, sexuality, and substance use. Previous studies such as Merrill et al. (1999) and AbdelGhany and Wang (2003) have used these data to examine determinants of youth marijuana use.
The state surveys are coordinated by the CDC and are administered by state education and health agencies. Like the national YRBS, the state YRBS is school-based and contains multiple items designed to elicit information on risky behaviors. To our knowledge, no previous study has used state YRBS data to examine the determinants of youth marijuana use.
Our analysis draws on both of these data sources in order to ensure that identification is based on as many MML changes as possible. Although intended to be nationally representative, not all 50 states are represented in any given wave of the national YRBS. In fact, between 1993
and 2011, only 6 states contributed data to the national YRBS every year (California, Florida, Georgia, Michigan, New York, and Texas), and 11 states contributed data to the national YRBS before and after the legalization of medical marijuana (Arizona, California, Colorado, Delaware, Hawaii, Maine, Michigan, New Jersey, New Mexico, Oregon, and Washington). Appendix 6 The national YRBS was first conducted in 1991. However, because the 1991 wave is based on only a handful of schools, we chose to omit it from the analysis.
8 states; sixteen of these states contributed data before and after the legalization of medical marijuana.
9 Table 1 provides descriptive statistics for the national and state YRBS samples by whether medical marijuana was legal at the time of the interview. According to the national YRBS data, 22 percent of high school students used marijuana at least once in the past 30 days, 9 and 9 percent used marijuana at least 10 times during the past 30 days (our definition of frequent use). In the state YRBS data, 21 percent of respondents used marijuana in the past 30 days and 8 percent were frequent users. Figures 3 and 4 present pre-and post-legalization trends in marijuana use based on national and state YRBS data, respectively. We report marijuana use for the three years prior to legalization, the year in which the law changed (year 0), and the three years following legalization. These figures provide simple and direct tests for whether youth marijuana consumption changed with the legalization of medical marijuana. In Figure 3 , there appears to be a small decrease in marijuana use immediately after legalization, followed by an increase of comparable magnitude. A similar pattern is evident in Figure 4 : marijuana use decreases immediately after legalization, increases after one year, and then decreases again by a comparable amount after two years. Although neither figure provides strong evidence of an increase in marijuana use after legalization, other factors related to, for instance, economic conditions could be masking the impact of legalization.
STATISTICAL METHODS
In an effort to control for economic conditions and other policies (as well as any changes in the composition of the YRBS), we turn to a standard regression framework that exploits both temporal and spatial variation in MMLs. Specifically, we estimate the following equation:
( whether marijuana use and possession was decriminalized, the presence of a BAC 0.08 law, the state beer tax, income per capita, and the unemployment rate. Previous research has shown that marijuana use is sensitive to decriminalization (Saffer and Chaloupka 1999) , alcohol policies (Pacula 1998; DiNardo and Lemieux 2001) and economic conditions (Hammer 1992) . All regressions are estimated as linear probability models and standard errors are corrected for clustering at the state level (Bertrand et al. 2004 ). In addition to examining marijuana use in the past 30 days, we examine frequent marijuana use, marijuana use at school, whether the 11 respondent was offered or bought marijuana on school property, and the use of other substances including alcohol and cocaine. Descriptive statistics for these outcomes are presented in Table 1 .
RESULTS
Tables 2 through 5 present unweighted OLS estimates of the relationship between MMLs and the outcomes discussed above. Separate estimates for the national and state YRBS are presented along with estimates based on the combined data.
Using the national YRBS and a "bare bones" specification without covariates or statespecific linear time trends, legalization of medical marijuana is associated with a 5.6 percentage point decrease in the probability of marijuana use within the past 30 days, and a 3.5 percentage point decrease in the probability of frequent use (Table 2) . We can reject the hypothesis that the relationship between MMLs and these outcomes is positive at conventional levels. The same specification yields smaller, but still negative, estimates of β 1 using the state YRBS data. When the national and state YRBS data are combined, we find that the legalization of medical marijuana is associated with a 2.1 percentage point decrease in the probability of marijuana use within the past 30 days, and a 1.1 percentage point decrease in the probability of frequent use.
We can reject the hypothesis that the relationship between legalization and these outcomes is positive at conventional levels. In Table 3 , we explore whether the relationship between MMLs and marijuana use depends on gender. These estimates are from our preferred specification that includes the full set of covariates and state-specific linear time trends. With one exception, they are negative and statistically indistinguishable from zero. The hypothesis that β 1 for male respondents is equal to β 1 for female respondents is never rejected. Table 4 compares estimates of β 1 for YRBS respondents who were under the age of 17 when they were interviewed with estimates for respondents who were 17 years of age or older.
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In the national YRBS data, the relationship between legalization and marijuana use is negative and significant among respondents under the age of 17, but insignificant among respondents 17 10 Appendix th graders since 1991. However, state identifiers are generally not made available to researchers. Our efforts to obtain these data were politely rebuffed. 12 The YRBS data include information on all high school students, some of whom are as old as 19.
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years of age and older. The relationship between legalization and frequent use is negative (but statistically insignificant) among both younger and older respondents. The remaining estimates of β 1 in Table 4 are small and statistically insignificant.
13 Table 5 reports estimates of the effect of legalization on the use of marijuana on school property in the past 30 days and estimates of the effect of legalization on the probability a student reported having been offered, sold, or given an illegal drug at school in the past year.
These estimates are of particular interest given the recent attempts to close dispensaries operating near schools (Brooks 2012; McCrimmon and Jones 2012) . The estimated relationship between MMLs and the use of marijuana on school property is consistently negative, but never statistically significant. In the combined sample, legalization is associated with a 2.7 percentage point decrease in the probability of having been offered, sold, or given an illegal drug at school in the past year Finally, we examine the relationship between the legalization of medical marijuana and the use of other substances in Table 6 . Using a regression discontinuity design, Crost and Guerrero (2012) found that marijuana use decreased sharply at the age of 21, suggesting that marijuana and alcohol are substitutes. Other studies suggest that marijuana and substances such as alcohol and cocaine are complements (Saffer and Chaloupka 1999; DeSimone and Farrelly 2003; Williams et al. 2004; Yörük and Yörük 2011) . Our results provide little evidence that the legalization of medical marijuana leads to increased use of alcohol or cocaine. 13 Although the results are not reported, we estimated equation (1) for respondents 18 years of age and older. There was no evidence that the legalization of medical marijuana was associated with an increase in marijuana use among this age group. Appendix Table 5 presents estimates that incorporate the sample weights provided by the national YRBS. They are similar to those reported in Table 3 and Table 4 .
Analysis of the National Longitudinal Survey of Youth 1997
In this section, we examine the relationship between MMLs and the use of marijuana by youth in the National Longitudinal Survey of Youth 1997 (NLSY97). The NLSY97, which is conducted annually, is a nationally representative sample of individuals who were 12 through 16 years of age as of December 31 st , 1996. It contains detailed information on educational attainment, family background and socio-economic status, and its respondents are asked a host questions with regard to marijuana use including, "On how many days have you used marijuana in the last 30 days?" 14 Because our focus is on teenagers, we limit the analysis to respondents ages 12 through 19 at the time of the survey.
There are two primary benefits to using the NLSY97 data. First, unlike the YRBS, the NLSY97 includes high school dropouts. This is important because high school dropouts are more likely to use marijuana than their counterparts who stay in school (Bray et al. 2000) .
Second, because the NLSY97 data follow adolescents over time, it is possible to control for unobserved heterogeneity at the individual level.
However, there are two significant drawbacks to using NLSY97 data. First, California legalized medical marijuana before data collection began and several other states legalized medical marijuana when most of the NLSY97 respondents were in their twenties and thirties. 15 Second, several of the states that legalized medical marijuana in the late 1990s and early 2000s
contributed only a handful of observations to the NLSY97.
14 Based on the answers to this question, we are able to construct measures of marijuana use that correspond to the marijuana use measures in the YRBS data. Economists who have used these data to study determinants of marijuana use include Aughinbaugh and Gittleman (2004) , Cowen (2011) , and Yörük and Yörük (2011) . Because NLSY97 respondents are observed in multiple years, we are able to include individual fixed effects, λ i , on the right-hand side of the estimating equation. In addition to absorbing time-invariant heterogeneity at the individual level, these effects account for factors at the state level that may be correlated with marijuana use and the legalization of medical marijuana, although it is important to note that identification comes from changes in the law and from movement between states with different MMLs. All regressions are estimated as linear probability models and standard errors are corrected for clustering at the state level (Bertrand et al. 2004 ).
Each cell in Table 8 represents the results from a separate regression. Estimates in column (1) are based on a specification that includes only individual and year fixed effects; estimates in column (2) are based on a specification that also includes the covariates listed in estimates are taken at face value, the legalization of medical marijuana is associated with a 0.7 percentage point increase in the probability of marijuana use in the past 30 days, and a 1.3
percentage point increase in the probability of frequent use. Appendix Table 6 presents estimates that incorporate the sample weights provided by the NLSY97. 17 They are consistent with those reported in Table 8 .
Analysis of the Treatment Episode Data Set
Finally, we examine the relationship between MMLs and marijuana use based on statelevel data from the Treatment Episode Data Set (TEDS) for the period 1992 through 2009.
Federally funded drug treatment facilities are required to provide information to TEDS including whether a patient reported using marijuana prior to admission. Using these data, we constructed rates of marijuana use at the state level by year.
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There are at least two advantages to using the TEDS data. First, like the NLSY97, the TEDS data include high school dropouts. Second, the TEDS data are compiled annually and very few states fail to provide admissions data. In contrast, the YRBS data are collected biennially and only a subset of states contribute data in any given year. Descriptive statistics for the TEDS data are presented in Table 9 .
17 Following Mellor (2011), we used the average of the sample weights for each individual for the years in which he or she participated in the NLSY97. 18 Other economists who have used these data include Anderson (2010) , Corman et al. (2010) , Cunningham and Finlay (2011), and Nonnemaker et al. (2011 where a indexes whether the observed admission rate is for males or females, s indexes states, and t indexes years. The dependent variable is the natural logarithm of the sex-specific marijuana admissions rate per 100,000 of the relevant population. Because TEDS does not provide the exact age or date of birth, we consider marijuana admission rates for two age groups:
15-through 17-year-olds and 18-through 20-year-olds. Again, the variable MML st indicates whether a MML was in effect in state s and year t, the vector X st is composed of the controls described in Table 9 , and v s and w t are state and year fixed effects, respectively, and state-specific linear time trends are represented by Θ s • t. 
CONCLUSION
Medical marijuana is popular with the general public. A recent Gallup poll found that 70 percent of Americans say they favor making marijuana legally available for doctors to prescribe in order to reduce pain and suffering (Mendes 2010).
Given this level of support, it could be viewed as surprising that only 17 states have legalized medical marijuana. However, opponents of medical marijuana have employed a number of effective arguments, several of which focus on the use of marijuana by teenagers. For instance, Montana State Senator Jeff Essmann was quoted in 2011 as saying, "The number one goal is to reduce access and availability to the young people of this state that are being sent an incorrect message that this is an acceptable product for them to be using" (Florio 2011 ).
In order to examine the relationship between medical marijuana laws and youth consumption, we draw on data from the national and state Youth Risk Behavior Surveys (YRBS)
for the years 1993 through 2011. These data cover a period when 16 states, including California, Colorado, Montana, Oregon and Washington, legalized medical marijuana, and allow us to estimate the effect of legalization on outcomes such as marijuana use in the past month, frequent marijuana use, and the use of other substances such as alcohol and cocaine.
Our results are not consistent with the hypothesis that the legalization of medical marijuana caused an increase in the use of marijuana and other substances among high school students. In fact, estimates from our preferred specifications are consistently negative and are never statistically distinguishable from zero. Using the 95 percent confidence interval around these estimates suggests that the impact of legalizing medical marijuana on the probability of marijuana use in the past 30 days is no larger than 0.8 percentage points, and the impact of In addition to the YRBS analysis, we examine data from the National Longitudinal Survey of Youth 1997 (NLSY97) and the Treatment Episode Data Set (TEDS). The NLSY97 allows us to follow survey respondents over time, while the TEDS data allow us to examine a high-risk population. There is little evidence that marijuana use is related to the legalization of medical marijuana in either of these data sources, a result that is consistent with research
showing that marijuana use among adults is more sensitive to changes in policy than marijuana use among youths (Farrelly et al. 1999; Williams 2004 ).
Although our estimates do not lend support to the often-voiced argument that legalization leads to increased consumption of marijuana among teenagers, it is important to note that our study has at least one limitation: the YRBS data are only available through 2011 and the TEDS data are only available through 2009. In the past year, several states have seen dramatic changes to the market for medical marijuana. For instance, as a result of Drug Enforcement Agency raids, the number of providers in Montana has plummeted. As future waves of the YRBS are released, researchers will be in a position to update our estimates and explore whether these changes have affected the behavior of teenagers. (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) . The dependent variable is equal to the natural log of the marijuana admissions rate per 100,000 population; the covariates are listed in Table 9 . Regressions are weighted using the relevant state age-and gender-specific populations. Standard errors, corrected for clustering at the state level, are in parentheses. state-level, are in parentheses.
